EPCAM and neoplasm: Houvast and colleagues recently designed two ankyrin repeat proteins (DARPins) targeting EpCAM that have been validated for their ability to provide clear tumor delineation in preclinical models, indicating their potential for pan-carcinoma visualization [72].